Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 85

Sort by

Sort Order Select

Journal Articles

Activity of CAR-T Cells and Bispecific Antibodies in Multiple Myeloma with Extramedullary Involvement

Blood (2024) 144 (Supplement 1): 3792.4.

https://doi.org/10.1182/blood-2024-206735

Published: 2024

Journal Articles

Loss of SMARCA4 Leads to an Impaired Hematopoiesis in Mice

Franziska Modemann, Leoni Ramke, Erkin Erdal, Melanie Schoof, Carolin Göbel, Sina Neyazi, Carsten Bokemeyer, Jasmin Wellbrock, Ulrich Schüller, Walter Fiedler

Blood (2023) 142 (Supplement 1): 1377.

https://doi.org/10.1182/blood-2023-178137

Published: 2023

Journal Articles

Isatuximab, Carfilzomib, Lenalidomide, and Dexamethasone (Isa-KRd) in Patients with High-Risk Newly Diagnosed Multiple Myeloma: Planned Interim Analysis of the GMMG-Concept Trial

Blood (2022) 140 (Supplement 1): 1836–1838.

https://doi.org/10.1182/blood-2022-156309

Published: 2022

Journal Articles

Molecular Response Patterns in Relapsed/Refractory AML Patients Treated with Selinexor and Chemotherapy

Blood (2021) 138 (Supplement 1): 2369.

https://doi.org/10.1182/blood-2021-151091

Published: 2021

Journal Articles

Blockade of Tigit on AML-Derived M2 Macrophages Results in Reprograming into the M1 Phenotype and Enhances CD47-Mediated Phagocytosis

Franziska Brauneck, Brit Fischer, Jasmin Wellbrock, Carsten Bokemeyer, Julian Schulze zur Wiesch, Friedrich Haag, Christin Ackermann, Walter Fiedler

Blood (2021) 138 (Supplement 1): 3351.

https://doi.org/10.1182/blood-2021-148075

Published: 2021

Journal Articles

A Comparative Outcome Analysis of COVID-19 and Influenza Infection in Patients with Hematological Malignancies

Susanne Ghandili, Christian Niederwieser, Katja Weisel, Carsten Bokemeyer, Walter Fiedler, Franziska Modemann

Blood (2021) 138 (Supplement 1): 2286.

https://doi.org/10.1182/blood-2021-147438

Published: 2021

Journal Articles

CD19+ B Lymphocytes Are Predictive for Anti-Sars-Cov-2 Vaccination Response in Multiple Myeloma Patients

Susanne Ghandili, Martin Schönlein, Heiko Becher, Christian Wiessner, Marc Lütgehetmann, Julian Schulze zur Wiesch, Carsten Bokemeyer, Marianne Sinn, Lisa Leypoldt, Katja Weisel

Blood (2021) 138 (Supplement 1): 3788.

https://doi.org/10.1182/blood-2021-149062

Published: 2021

Journal Articles

Immune thrombocytopenic purpura after vaccination with COVID-19 vaccine (ChAdOx1 nCov-19)

Finn-Ole Paulsen, Christoph Schaefers, Florian Langer, Christian Frenzel, Ulrich Wenzel, Felicitas E. Hengel, Carsten Bokemeyer, Christoph Seidel

Blood (2021) 138 (11): 996–999.

https://doi.org/10.1182/blood.2021012790

Published: 2021

Includes: Supplemental data

Journal Articles

Increased Frequency of TOX + CD39 + TIGIT + CD73 - CD8 + T Cells in Patients with Newly Diagnosed AML

Franziska Brauneck, MD, Christin Ackermann, PhD, Nils Wildner, Jasmin Wellbrock, PhD, Carsten Bokemeyer, MD, Julian Schulze zur Wiesch, MD, Walter Fiedler, MD

Blood (2020) 136 (Supplement 1): 36.

https://doi.org/10.1182/blood-2020-139917

Published: 2020

Journal Articles

Blockade of Mer By the Small Molecule Inhibitor R992 Inhibits Multiple Myeloma and Its Associated Bone Disease By Restoring the Perturbed Bone Homeostasis

Janik Engelmann, Isabel Ben Batalla, PhD, Hanna Taipaleenmäki, PhD, Kristoffer Riecken, PhD, Victoria Gensch, Sarina Paesler, Nikolaus Berenbrok, Maria Elena Vargas, Jonas Waizenegger, MD, Boris Fehse, PhD, Klaus Pantel, MD, PhD, Ihab S Darwish, PhD, Somasekhar Bhamidipati, PhD, Esteban Masuda, PhD, Carsten Bokemeyer, MD, PhD, Eric Hesse, MD, PhD, Sonja Loges, MD, PhD

Blood (2018) 132 (Supplement 1): 1922.

https://doi.org/10.1182/blood-2018-99-118273

Published: 2018

Journal Articles

Therapeutic Potential of Axl Blockade in BCR-ABL Negative Myeloproliferative Neoplasms (MPN)

Antonia Beitzen-Heineke, MD, Isabel Ben Batalla, PhD, Nikolaus Berenbrok, Sarina Paesler, Victoria Gensch, Gunhild von Amsberg, Philippe Schafhausen, MD, Kristoffer Riecken, PhD, Thomas Fischer, MD, Klaus Pantel, MD, PhD, Carsten Bokemeyer, MD, PhD, Sonja Loges, MD, PhD

Blood (2018) 132 (Supplement 1): 3063.

https://doi.org/10.1182/blood-2018-99-118175

Published: 2018

Journal Articles

BET-Inhibition By JQ1 Promotes Proliferation and Self-Renewal Capacity of Hematopoietic Stem Cells

Mark Wroblewski, PhD, Marina Scheller-Wendorff, PhD, Raimund Bauer, PhD, Florian Udonta, Jara Schlichting, Lin Zhao, MD, Isabel Ben Batalla, PhD, Victoria Gensch, Marek Wanior, Hanna Taipaleenmäki, PhD, Simona Bolamperti, PhD, Zeynab Najafova, PhD, Klaus Pantel, MD PhD, Carsten Bokemeyer, MD PhD, Eric Hesse, MD PhD, Stefan Knapp, PhD, Steven Johnsen, PhD, Sonja Loges, MD PhD

Blood (2017) 130 (Supplement 1): 1900.

https://doi.org/10.1182/blood.V130.Suppl_1.1900.1900

Published: 2017

Journal Articles

The Actin Binding Protein Plastin-3 Is Involved in the Pathogenesis of Acute Myeloid Leukemia

Arne Velthaus, Kerstin Cornils, PhD, Saskia Grüb, MSc, Hauke Stamm, MSc, Daniel Wicklein, PhD, Carsten Bokemeyer, MD, Michael Heuser, MD, Sabine Windhorst, PhD, Walter Fiedler, MD, Jasmin Wellbrock, PhD

Blood (2016) 128 (22): 1662.

https://doi.org/10.1182/blood.V128.22.1662.1662

Published: 2016

Journal Articles

Phase II Results of Ara-C and Idarubicin in Combination with the Selective Inhibitor of Nuclear Export (SINE) Compound Selinexor (KPT-330) in Patients with Relapsed or Refractory AML

Walter Fiedler, Michael Heuser, MD, Jörg Chromik, Felicitas Thol, Carsten Bokemeyer, MD, Susann Theile, Isabell Lebkuechner, Anne L. Kranich

Blood (2016) 128 (22): 341.

https://doi.org/10.1182/blood.V128.22.341.341

Published: 2016

Journal Articles

Opposite Effects of Bruton Tyrosine Kinase (BTK) Inhibitor Therapy with Ibrutinib and FCR Chemo-Immunotherapy on the Normal B Lymphocyte Repertoire in Patients with Chronic Lymphocytic Leukemia

Simon Schliffke, MD, Mariela Sivina, PhD, Ekaterina Kim, PhD, Benjamin Thiele, MD, Nuray Akyüz, PhD, Clemens Falker-Gieske, PhD, Toni Thenhausen, Artus Krohn-Grimberghe, PhD, Carsten Bokemeyer, MD, Nitin Jain, MD, Zeev Estrov, MD, Alessandra Ferrajoli, MD, William G. Wierda, MD PhD, Michael J. Keating, MD, Jan A. Burger, MD PhD, Mascha Binder, MD

Blood (2016) 128 (22): 4402.

https://doi.org/10.1182/blood.V128.22.4402.4402

Published: 2016

Journal Articles

A transplant “immunome” screening platform defines a targetable epitope fingerprint of multiple myeloma

Aneta Schieferdecker, Anna Oberle, Benjamin Thiele, Fabian Hofmann, Markus Göthel, Sebastian Miethe, Michael Hust, Friederike Braig, Mareike Voigt, Ute-Marie von Pein, Friedrich Koch-Nolte, Friedrich Haag, Malik Alawi, Daniela Indenbirken, Adam Grundhoff, Carsten Bokemeyer, Ulrike Bacher, Nicolaus Kröger, Mascha Binder

Blood (2016) 127 (25): 3202–3214.

https://doi.org/10.1182/blood-2015-10-676536

Published: 2016

Includes: Supplemental data

Journal Articles

Expression of Novel Immune Checkpoint Molecules PVR and PVRL2 Confers a Negative Prognosis to Patients with Acute Myeloid Leukemia and Their Blockade Augments T-Cell Mediated Lysis of AML Cells Alone or in Combination with the BiTE ® Antibody Construct AMG 330

Hauke Stamm, MSc, Felix Klingler, cand. MD, Daniela Pende, MD, Eik Vettorazzi, MSc, Michael Heuser, MD, Ulrike Mock, PhD, Carsten Bokemeyer, MD, Roman Kischel, MD, Sabine Stienen, PhD, Matthias Friedrich, PhD, Michael Lutteropp, PhD, Dirk Nagorsen, MD, Jasmin Wellbrock, PhD, Walter Fiedler, MD

Blood (2015) 126 (23): 789.

https://doi.org/10.1182/blood.V126.23.789.789

Published: 2015

Journal Articles

BGB324 Inhibits BCR-ABL TKI-Resistant Chronic Myeloid Leukemia

Blood (2015) 126 (23): 1569.

https://doi.org/10.1182/blood.V126.23.1569.1569

Published: 2015

Journal Articles

Expression and Release of Platelet Protein Disulfide (PDI) Isomerase Is Increased in Patients with Hemophilia a

Florian Langer, Minna Voigtländer, Katharina Holstein, Brigitte Spath, Walter Fiedler, MD, Carsten Bokemeyer, MD

Blood (2015) 126 (23): 1085.

https://doi.org/10.1182/blood.V126.23.1085.1085

Published: 2015

Journal Articles

Optimization of Rituximab for Treatment of DLBCL in Young, High-Risk Patients-Results of the Dense-R-CHOEP Trial of the German High-Grade Lymphoma Study Group

Norbert Schmitz, MD PhD, Maike Nickelsen, MD, Marita Ziepert, PhD, Mathias Haenel, MD, Andreas Viardot, MD, Martin H. Dreyling, MD PhD, Peter Borchmann, MD, Carsten Bokemeyer, MD, Christian Peschel, MD, Hans-Heinrich Wolf, MD, Rolf Mahlberg, MD, Michael Pfreundschuh, MD, Bertram Glass, MD

Blood (2015) 126 (23): 474.

https://doi.org/10.1182/blood.V126.23.474.474

Published: 2015

NARROW

Activity of CAR-T Cells and Bispecific Antibodies in Multiple Myeloma with Extramedullary Involvement

Loss of SMARCA4 Leads to an Impaired Hematopoiesis in Mice

Isatuximab, Carfilzomib, Lenalidomide, and Dexamethasone (Isa-KRd) in Patients with High-Risk Newly Diagnosed Multiple Myeloma: Planned Interim Analysis of the GMMG-Concept Trial

Molecular Response Patterns in Relapsed/Refractory AML Patients Treated with Selinexor and Chemotherapy

Blockade of Tigit on AML-Derived M2 Macrophages Results in Reprograming into the M1 Phenotype and Enhances CD47-Mediated Phagocytosis

A Comparative Outcome Analysis of COVID-19 and Influenza Infection in Patients with Hematological Malignancies

CD19+ B Lymphocytes Are Predictive for Anti-Sars-Cov-2 Vaccination Response in Multiple Myeloma Patients

Immune thrombocytopenic purpura after vaccination with COVID-19 vaccine (ChAdOx1 nCov-19)

Increased Frequency of TOX + CD39 + TIGIT + CD73 - CD8 + T Cells in Patients with Newly Diagnosed AML

Blockade of Mer By the Small Molecule Inhibitor R992 Inhibits Multiple Myeloma and Its Associated Bone Disease By Restoring the Perturbed Bone Homeostasis

Therapeutic Potential of Axl Blockade in BCR-ABL Negative Myeloproliferative Neoplasms (MPN)

BET-Inhibition By JQ1 Promotes Proliferation and Self-Renewal Capacity of Hematopoietic Stem Cells

The Actin Binding Protein Plastin-3 Is Involved in the Pathogenesis of Acute Myeloid Leukemia

Phase II Results of Ara-C and Idarubicin in Combination with the Selective Inhibitor of Nuclear Export (SINE) Compound Selinexor (KPT-330) in Patients with Relapsed or Refractory AML

Opposite Effects of Bruton Tyrosine Kinase (BTK) Inhibitor Therapy with Ibrutinib and FCR Chemo-Immunotherapy on the Normal B Lymphocyte Repertoire in Patients with Chronic Lymphocytic Leukemia

A transplant “immunome” screening platform defines a targetable epitope fingerprint of multiple myeloma

Expression of Novel Immune Checkpoint Molecules PVR and PVRL2 Confers a Negative Prognosis to Patients with Acute Myeloid Leukemia and Their Blockade Augments T-Cell Mediated Lysis of AML Cells Alone or in Combination with the BiTE ® Antibody Construct AMG 330

BGB324 Inhibits BCR-ABL TKI-Resistant Chronic Myeloid Leukemia

Expression and Release of Platelet Protein Disulfide (PDI) Isomerase Is Increased in Patients with Hemophilia a

Optimization of Rituximab for Treatment of DLBCL in Young, High-Risk Patients-Results of the Dense-R-CHOEP Trial of the German High-Grade Lymphoma Study Group

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only